Please login to the form below

Not currently logged in

Array Biopharma hires Dr Howard Holden as VP regulatory affairs

Will oversee attempts to bring to market pipeline of small molecule drugs to treat cancer and inflammatory diseases

Dr Howard Holden has joined Array Biopharma as VP of regulatory affairs and quality assurance.

Dr Holden will handle regulatory proceedings as the US biopharma aims to bring to market its pipeline of small molecule drugs to treat cancer and inflammatory diseases.

He has spent over 25 years in the pharma and biotech industry, including most recently 7 years at Nereus Pharmaceuticals as senior VP regulatory affairs and compliance.

Previously, Dr Holden was VP of regulatory affairs and compliance at Stressgen Biotechnologies and Ligand Pharmaceuticals; senior director at Parke-Davis/Warner-Lambert, director at Centocor and senior investigator at the US National Cancer Institute.

"Howard's lifetime of regulatory experience will help Array navigate the FDA approval path for our proprietary programmes," said Kyle Lefkoff, executive chair, Array BioPharma.

"He will make an immediate contribution as we move our pipeline into registration studies, and we're all excited to have Howard on the Array team."

27th April 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...